These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Regulation of immune responses by natural killer T cells. Sharif S; Delovitch TL Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 1():S23-31. PubMed ID: 11603866 [TBL] [Abstract][Full Text] [Related]
7. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells. Ly D; Mi QS; Hussain S; Delovitch TL J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329 [TBL] [Abstract][Full Text] [Related]
8. CD1d-restricted NKT regulatory cells: functional genomic analyses provide new insights into the mechanisms of protection against Type 1 diabetes. Mi QS; Meagher C; Delovitch TL Novartis Found Symp; 2003; 252():146-60; discussion 160-4, 203-10. PubMed ID: 14609217 [TBL] [Abstract][Full Text] [Related]
9. An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes. Ly D; Tohn R; Rubin B; Blumenfeld H; Besra GS; Veerapen N; Porcelli SA; Delovitch TL Clin Exp Immunol; 2010 May; 160(2):185-98. PubMed ID: 20015094 [TBL] [Abstract][Full Text] [Related]
10. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. Chen YG; Choisy-Rossi CM; Holl TM; Chapman HD; Besra GS; Porcelli SA; Shaffer DJ; Roopenian D; Wilson SB; Serreze DV J Immunol; 2005 Feb; 174(3):1196-204. PubMed ID: 15661873 [TBL] [Abstract][Full Text] [Related]
11. During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment. Duthie MS; Kahn SJ Immunology; 2006 Nov; 119(3):355-61. PubMed ID: 16879622 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes. Tohn R; Blumenfeld H; Haeryfar SM; Veerapen N; Besra GS; Porcelli SA; Delovitch TL Clin Exp Immunol; 2011 Apr; 164(1):26-41. PubMed ID: 21361909 [TBL] [Abstract][Full Text] [Related]
13. Immunoregulation of autoimmunity by natural killer T cells. Linsen L; Somers V; Stinissen P Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406 [TBL] [Abstract][Full Text] [Related]
14. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616 [TBL] [Abstract][Full Text] [Related]
15. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Burdin N; Brossay L; Kronenberg M Eur J Immunol; 1999 Jun; 29(6):2014-25. PubMed ID: 10382765 [TBL] [Abstract][Full Text] [Related]
16. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616 [TBL] [Abstract][Full Text] [Related]
17. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. Hussain S; Delovitch TL J Immunol; 2007 Dec; 179(11):7225-32. PubMed ID: 18025164 [TBL] [Abstract][Full Text] [Related]
18. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Matsuda H; Suda T; Sato J; Nagata T; Koide Y; Chida K; Nakamura H Am J Respir Cell Mol Biol; 2005 Jul; 33(1):22-31. PubMed ID: 15802553 [TBL] [Abstract][Full Text] [Related]
19. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321 [TBL] [Abstract][Full Text] [Related]
20. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. Singh AK; Wilson MT; Hong S; Olivares-Villagómez D; Du C; Stanic AK; Joyce S; Sriram S; Koezuka Y; Van Kaer L J Exp Med; 2001 Dec; 194(12):1801-11. PubMed ID: 11748281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]